92
127M
62
5.11
23
0.33
10
- Stages of investment
- Areas of investment
Summary
PremjiInvest is the famous VC, which was founded in 2006. The leading representative office of defined VC is situated in the Bangalore. The venture was found in Asia in India.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the PremjiInvest, startups are often financed by Salesforce Ventures, Shasta Ventures, Crosslink Capital. The meaningful sponsors for the fund in investment in the same round are Meritech Capital Partners, Tiger Global Management, Temasek Holdings. In the next rounds fund is usually obtained by Temasek Holdings, Unilazer Ventures, SoftBank Telecom Corp.
The overall number of key employees were 2.
Among the most popular portfolio startups of the fund, we may highlight Snapdeal, Looker, Devoted Health. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Among the most popular fund investment industries, there are FinTech, Shopping.
The fund is constantly included in 2-6 deals per year. The usual things for fund are deals in the range of 50 - 100 millions dollars. The higher amount of exits for fund were in 2018. The typical startup value when the investment from PremjiInvest is 500 millions - 1 billion dollars. The important activity for fund was in 2015. Despite it in 2019 the fund had an activity. Opposing the other organizations, this PremjiInvest works on 0 percentage points less the average amount of lead investments. Speaking about the real fund results, this VC is 48 percentage points more often commits exit comparing to other organizations.
Investments analytics
Analytics
- Total investments
- 92
- Lead investments
- 23
- Exits
- 10
- Rounds per year
- 5.11
- Follow on index
- 0.33
- Investments by industry
- E-Commerce (20)
- Software (20)
- Retail (15)
- Financial Services (15)
- Health Care (14) Show 104 more
- Investments by region
-
- United States (43)
- India (49)
- Peak activity year
- 2021
- Number of Unicorns
- 19
- Number of Decacorns
- 20
- Number of Minotaurs
- 5
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 1B
- Group Appearance index
- 0.78
- Avg. company exit year
- 14
- Avg. multiplicator
- 1.67
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Devoted Health | 11 Oct 2018 | Health Care, Hospital, Elderly, Elder Care | Early Stage Venture | 300M | United States, Massachusetts |
| Enveda Biosciences | 14 Jun 2024 | Biotechnology, Pharmaceutical, Therapeutics | Early Stage Venture | 55M | United States, California, San Francisco |
| 01 Jun 2016 | Education | Seed | Switzerland, Vaud, Chavannes |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.